Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind CEO Demis Hassabis has said that AI can have a serious crack at solving all diseases in the coming years. And ...

Pascal Donohoe, President of the Eurogroup and Ireland's Minister of Finance, discusses his priorities for the Eurogroup in ...

Keep your eye makeup flawless for less. Julie Bowen Thought ‘Happy Gilmore 2' Would Replace Her With a ‘Younger Woman': ‘I ...

Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Investors are worried about Google's falling market share. The Google Search engine saw its revenue rise 10% in Q1. Alphabet ...